This article has been corrected: The Supplementary Table 2 has been updated to show the appropriate WUSTL numbers in the first column. The corrected Table 2, produced using the original data, is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.
Supplementary Table 2. Mitotic index.
| Case | Mitoses | Tumor Type |
|---|---|---|
| WU-1 | 74/10 HPF | MPNST |
| WU-2 | 17/10 PF | MPNST |
| WU-3 | 19/10 PF | MPNST |
| WU-4 | 28/10 HPF | MPNST |
| WU-5 | 78/10 HPF | MPNST |
| WU-6 | 4/10 HPF | MPNST |
| WU-7 | 6/10 HPF | MPNST |
| WU-8 | 5/10 HPF | MPNST |
| WU-9 | 81/10 HPF | MPNST |
| WU-10 | 11/10 HPF | MPNST |
| WU-11 | * | MPNST |
| WU-12 | 25/10 HPF | MPNST |
| WU-13 | 3/10 HPF | MPNST |
| WU-14 | 8/10 HPF | MPNST |
| WU-15 | 25/10 HPF | MPNST |
| WU-16 | 32/10 HPF | MPNST |
| WU-17 | 27/10 HPF | MPNST |
| WU-18 | **Metastatic lesion | MPNST |
| WU-19 | 9/10 HPF | MPNST |
| WU-20 | 27/10 HPF | MPNST |
| WU-21 | 6/10 HPF | MPNST |
| WU-22 | 8/10 HPF | MPNST |
| WU-23 | 6/10 HPF | MPNST |
| WU-24 | 4/10 HPF | MPNST |
| WU-25 | 3/10 HPF | MPNST |
| WU-26 | 23/10 HPF | MPNST |
| WU-27 | 15/10 HPF | MPNST |
| WU-28 | 4/10 HPF | MPNST |
| WU-29 | 20/10 HPF | MPNST |
| WU-30 | 21/10 HPF | MPNST |
| WU-31 | 69/10 HPF | MPNST |
| WU-32 | 9/10HPF | MPNST |
| WU-33 | 7/10 HPF | MPNST |
| WU-34 | 55/10 HPF | MPNST |
| WU-35 | **Metastatic lesion | MPNST |
| WU-36 | 23/10 HPF | MPNST |
| WU-37 | 20/10 HPF | MPNST |
| WU-38 | 8/10 HPF | MPNST |
| WU-39 | 14/10 HPF | MPNST |
| WU-40 | 62/10 HPF | MPNST |
| WU-41 | >1/50 HPF | Atypical Neurofibroma |
| WU-42 | >1/50 HPF | Atypical Neurofibroma |
| WU-43 | >1/50 HPF | Atypical Neurofibroma |
| WU-44 | >1/50 HPF | Atypical Neurofibroma |
| WU-45 | >1/50 HPF | Atypical Neurofibroma |
| WU-46 | >1/50 HPF | Atypical Neurofibroma |
| WU-47 | 0 (small biopsy) | Atypical Neurofibroma |
| WU-48 | 0 (small biopsy) | Atypical Neurofibroma |
| WU-49 | 0 (small biopsy) | Atypical Neurofibroma |
*Brisk mitotic activity per pathology report. All slides not available for current review. **Mitotic count was not performed on metastatic lesions.
Original article: Oncotarget. 2018; 9:23018–23028. 23018-23028. https://doi.org/10.18632/oncotarget.25195